Serum inorganic fluoride levels in obese patients during and after enflurane anesthesia.
Serum ionic fluoride levels in 24 markedly obese patients (127.6 +/- 6.0 kg) and seven nonobese control subjects (67.3 +/- 1.2 kg) were compared during and following enflurane anesthesia (less than 2.0 MAC hr). Peak serum fluoride levels were higher (28.0 +/- 1.9 vs 17.3 +/- 1.3 micrometers/L, p less than 0.01) and the rate at which fluoride levels increased was more rapid (slope 5.6 vs 2.5 micrometers/L/hr) in obese patients than in control patients. No clinical evidence of nephrotoxicity was found in either group. Vasopressin resistance tests were not performed, and thus it is inknown whether subclinical nephrotoxicity occurred in either study group. Possible reasons for increased enflurane metabolism in obesity are discussed. These possibilities include differences in fluoride ion kinetics, hepatic delivery and penetration of volatile anesthetics, and altered hepatic microsomal enzyme activity. Obesity rather than weight is an important determinant of anesthetic biotransformation.
D000328:Adult; D000769:Anesthesia, Inhalation / Q000009:adverse effects; D001711:Biotransformation; D002849:Chromatography, Gas; D004737:Enflurane / Q000009:adverse effects / Q000378:metabolism*; D005459:Fluorides / Q000097:blood*; D006801:Humans; D007668:Kidney / Q000187:drug effects; D007677:Kidney Function Tests; D008875:Middle Aged; D009765:Obesity / Q000378:metabolism*; D011184:Postoperative Period; D012044:Regression Analysis; D013997:Time Factors
D004737:Enflurane; D005459:Fluorides